Evidence map›Paper›PMID 33210602›Full record

ArticleeLife2020

Plasma proteomic biomarker signature of age predicts health and life span.

Toshiko Tanaka, Nathan Basisty, Giovanna Fantoni, Julián Candia, Ann Z Moore, Angelique Biancotto, Birgit Schilling, Stefania Bandinelli, Luigi Ferrucci

Registry-linked trialAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06975111 (Focusing on the Menopausal Transition to Improve Mid-Life Women's Health), which is not on this map. Cited by 148 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06975111 phase2 / phase3recruitingstarted 2026, after this paper: background citation

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Ran2026Enrolled200Registered outcomes10Posted comparisons0ConditionsCardiovascular, Menopause, Menopause Hot Flashes, Menopause Related ConditionsArmsAnti-hypertensives, Fezolinetant, Hormonal therapy, Life Style Intervention, Lipid Lowering Medication
Open the trial in the graph
3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Proteomic Markers of Aging and Longevity: A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Pooled it
  3. Biomarkers of Cellular Senescence Predict the Onset of Mobility Disability and Are Reduced by Physical Activity in Older Adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Urinary metabolic age from high-resolution nuclear magnetic resonance spectroscopy reveals longitudinal aging patterns.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Toshiko TanakaTranslational Gerontology Branch, National Institute on Aging, NIH, Baltimore, United States.ORCID 0000-0002-4161-3829
Nathan BasistyThe Buck Institute for Research on Aging, Novato, United States.
Giovanna FantoniNational Institute on Aging, Intramural Research Program, Clinical Research Core, NIH, Baltimore, United States.
Julián CandiaLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States.ORCID 0000-0001-5793-8989
Ann Z MooreTranslational Gerontology Branch, National Institute on Aging, NIH, Baltimore, United States.
Angelique BiancottoPrecision Immunology, Immunology & Inflammation Research Therapeutic Area, Sanofi, Cambridge, United States.
Birgit SchillingThe Buck Institute for Research on Aging, Novato, United States.ORCID 0000-0001-9907-2749
Stefania BandinelliGeriatric Unit, Azienda Sanitaria toscana centro, Firenze, Italy.
Luigi FerrucciTranslational Gerontology Branch, National Institute on Aging, NIH, Baltimore, United States.ORCID 0000-0002-6273-1613

Funding

Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for AgingU01AG060906 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI SCHILLING, BIRGIT · 2018 to 2022
$4.0M
HISPANIC SECONDARY STROKE PREVENTION INITIATIVER01MD009164 · NIMHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRASQUILLO, OLVEEN · 2014 to 2018
$1.9M
Quantitating, Targeting, and Phenotyping In Vivo Cellular Senescence in HumansK99AG065484 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI BASISTY, NATAN BOHDONIVICH · 2020 to 2021
$158k
NIA NIH HHS K99 AG065484NIA NIH HHS U01 AG060906NIH HHS K99 AG065484NIH HHS U01 AG060906NIMHD NIH HHS R01 MD009164
6 · The paper itself

Abstract

Older age is a strong shared risk factor for many chronic diseases, and there is increasing interest in identifying aging biomarkers. Here, a proteomic analysis of 1301 plasma proteins was conducted in 997 individuals between 21 and 102 years of age. We identified 651 proteins associated with age (506 over-represented, 145 underrepresented with age). Mediation analysis suggested a role for partial

Indexed as

AdultAgedAged, 80 and overAgingBiomarkersBlood ProteinsFemaleHumansMaleMiddle AgedProteomicsRisk FactorsYoung AdultBiomarkersBlood Proteinsagingbiomarkercomputational biologyepidemiologyglobal healthhealthspanhumanproteomicssystems biology

Identifiers

PMID33210602
PMCPMC7723412

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.